Healthcare
Singapore project develops AI from routine blood tests
The BloodCounts! project plans to build AI models from complete blood count data to support earlier disease detection, prognosis and clinical decisions.
A Singapore-linked BloodCounts! project will use complete blood count data and AI to identify subtle patterns in blood cells associated with disease. The project aims to develop frontier AI models that can support earlier disease detection, prognosis and clinical decision-making. Complete blood count testing is routinely used in healthcare, so the project seeks to extract additional information from an existing diagnostic source. The approach could reveal patterns that are difficult to identify through conventional review of individual measurements. The reported goal is not limited to one disease but spans a range of conditions. If successful, the models could help clinicians identify risk earlier and improve assessment of likely outcomes. The project is also described as having potential applications in Singapore and internationally. The source does not report completed clinical validation or routine deployment, so the work remains a development initiative. Its importance lies in applying advanced analytics to widely available laboratory data, potentially expanding the usefulness of routine blood tests without requiring a new test for every condition. Such tools could support clinicians while preserving clinical decision-making and further investigation.
Original source: Malay Mail